Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Fetal development of subcutaneous white adipose tissue is dependent on Zfp423

Shao M., Hepler C., Vishvanath L., MacPherson KA., Busbuso NC., Gupta RK.

Animal Study on Type 2 Diabetes, published in Mol Metab (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Mol Metab (2017)
Reported sample size
—
Source database
Europe PMC
PMID
28123942
PMCID
PMC5220400
DOI
10.1016/j.molmet.2016.11.009
Citations
50

Abstract (original English)

Objective Zfp423 is a multi zinc-finger transcription factor expressed in preadipocytes and mature adipocytes in vivo . Our recent work has revealed a critical role for Zfp423 in maintaining the fate of white adipocytes in adult mice through suppression of the beige cell thermogenic gene program; loss of Zfp423 in mature adipocytes of adult mice results in a white-to-beige phenotypic switch. However, the exact requirements of Zfp423 in the fetal stages of early adipose development in vivo have not been clarified. Method Here, we utilize two models that confer adipose-specific Zfp423 inactivation during fetal adipose development ( Adiponectin -Cre; Zfp423 loxP/loxP and Adiponectin -rtTA; TRE-Cre; Zfp423 l oxP/loxP ). We assess the impact of fetal adipose Zfp423 deletion on the initial formation of adipose tissue and evaluate the metabolic consequences of challenging these animals with high-fat diet feeding. Results Deletion of Zfp423 during fetal adipose development results in a different phenotype than is observed when deleting Zfp423 in adipocytes of adult mice. Inactivation of Zfp423 during fetal adipose development results in arrested differentiation, specifically of inguinal white adipocytes, rather than a white-to-beige phenotypic switch that occurs when Zfp423 is inactivated in adult mice. This is likely explained by the observation that adiponectin driven Cre expression

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsMice, TransgenicMiceInsulin ResistanceObesityDNA-Binding ProteinsTranscription FactorsCell DifferentiationThermogenesis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research